Pilot Study of Preoperative Intestinal Training Using Antegrade Ileostomy Infusion
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Jun 11, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help patients prepare for a surgery that reverses their ostomy, known as an ostomy takedown. The researchers want to see if infusing contents from the ostomy bag back into the intestine can help "re-train" the intestine before the surgery. Since the part of the intestine beyond the ostomy hasn’t been processing food for a while, it may need some help to get back to normal after the surgery. By using this method, the goal is to speed up the recovery process and help patients regain normal intestinal function more quickly.
To be eligible for this study, participants need to have a specific type of ostomy called a diverting loop ileostomy and be preparing for the takedown surgery. The study is open to adults aged between 18 and 75. If you choose to participate, you would be involved in a process of infusing material from your ostomy into your intestines before your surgery, which will be closely monitored by the research team. It's important to note that this trial is not yet recruiting participants, but it presents a potential new way to support recovery for those with ostomies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Has a diverting loop ileostomy
- • undergoing evaluation for stoma takedown
- Exclusion Criteria:
- • unable to perform consent
- • unable to perform stoma infusion
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported